≡

Multiplex Assay Kit for Macrophage Inflammatory Protein 3 Beta (MIP3b) ,etc. by FLIA (Flow Luminescence Immunoassay)

CCL19; CKb11; ELC; MIP3-B; SCYA19; Chemokine C-C-Motif Ligand 19; Beta Chemokine Exodus-3; CK Beta-11; EBI1-Ligand Chemokine; Small Inducible Cytokine Subfamily A19

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Macrophage Inflammatory Protein 3 Beta (MIP3b) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Macrophage Inflammatory Protein 3 Beta (MIP3b) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Macrophage Inflammatory Protein 3 Beta (MIP3b) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Macrophage Inflammatory Protein 3 Beta (MIP3b) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 91-98 95
EDTA plasma(n=5) 92-101 96
heparin plasma(n=5) 80-101 90
sodium citrate plasma(n=5) 78-101 85

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Macrophage Inflammatory Protein 3 Beta (MIP3b) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Macrophage Inflammatory Protein 3 Beta (MIP3b) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Macrophage Inflammatory Protein 3 Beta (MIP3b) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 85-103% 99-105% 89-104% 95-103%
EDTA plasma(n=5) 98-105% 81-102% 79-96% 79-91%
heparin plasma(n=5) 78-102% 80-98% 94-101% 81-101%
sodium citrate plasma(n=5) 97-104% 89-96% 80-95% 81-101%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:MIP3b) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
BMC Veterinary Research MIP-3beta/CCL19 is associated with the intrathecal invasion of mononuclear cells in neuroinflammatory and non-neuroinflammatory CNS diseases in dogs Pubmed:25016392
Brain, Behavior, and Immunity Plasma inflammatory biomarkers for Huntington’s disease patients and mouse model Pubmed:25266150
Brain, Behavior, and Immunity Plasma inflammatory biomarkers for Huntington’s disease patients and mouse model PubMed: 25266150
类风湿关节炎血清中CCL19 和CCL21 的表达水平与肺间质病变的关系 :
Catalog No. Related products for research use of Canis familiaris; Canine (Dog) Organism species Applications (RESEARCH USE ONLY!)
RPA096Ca01 Recombinant Macrophage Inflammatory Protein 3 Beta (MIP3b) Positive Control; Immunogen; SDS-PAGE; WB.
PAA096Ca01 Polyclonal Antibody to Macrophage Inflammatory Protein 3 Beta (MIP3b) WB; IHC; ICC; IP.
MAA096Ca21 Monoclonal Antibody to Macrophage Inflammatory Protein 3 Beta (MIP3b) WB; IHC; ICC; IP.
SEA096Ca ELISA Kit for Macrophage Inflammatory Protein 3 Beta (MIP3b) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA096Ca Multiplex Assay Kit for Macrophage Inflammatory Protein 3 Beta (MIP3b) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
PGA096Ca01 Primer Pair for Macrophage Inflammatory Protein 3 Beta (MIP3b) PCR